Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-21-012179

Gould Robert J sold 10,000 shares at an average $12.16 ($121,578)

From the SEC's structured data for this filing

Trades in this filing

Gould Robert J

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-15 Sale : show line 1 in the form −9,211 $12.13 $111,773 507,419 D
2021-03-16 Sale : show line 2 in the form −789 $12.43 $9,806 506,630 D
Open-market sales · 10,000 sh · avg $12.16 · $121,578
Loading xslF345X03/doc4.xml…